## Core Concept
The question revolves around the diagnosis and management of congenital syphilis, which occurs when a pregnant woman with syphilis passes the infection to her unborn child. The Venereal Disease Research Laboratory (VDRL) test is a nontreponemal serologic screening for syphilis. Understanding the factors that influence the risk of mother-to-child transmission (MTCT) of syphilis is crucial for providing appropriate care.

## Why the Correct Answer is Right
The correct answer involves understanding that certain factors help in determining the risk of transmission of syphilis from mother to child. These factors typically include the mother's stage of syphilis, the presence of active lesions, the duration of infection, and the adequacy of prenatal care. The VDRL titer is a significant indicator; higher titers are associated with a greater risk of congenital syphilis.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, factors such as maternal VDRL titer, presence of active lesions, gestational age at treatment, and adequacy of maternal treatment are considered.
- **Option B:** Similarly, this option is missing but could relate to other relevant factors like the timing of maternal treatment (whether it was given before or during pregnancy) and the infant's physical examination and lab results.
- **Option C:** Without specifics, we assume it relates to another factor; usually, clinical and laboratory findings in the infant, such as physical examination and cerebrospinal fluid analysis, are crucial.
- **Option D:** The statement regarding the exception likely points to an option that does not directly influence the determination of the risk of transmission.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that the risk of congenital syphilis can be significantly reduced if the mother receives appropriate antibiotic treatment during pregnancy. Early screening and treatment are key. A VDRL-reactive mother should undergo thorough evaluation and treatment to prevent congenital syphilis.

## Correct Answer: D.